Regulation & law · 07/08/2012Updated: 10/17/2026 · 1 min read
AMRI Rensselaer, Inc. Submits Notice of Application for Manufacturer of Controlled Substances
Summary
AMRI Rensselaer, Inc. has submitted a notice of application to the relevant authorities, seeking approval to manufacture controlled substances, as part of its ongoing efforts to expand its portfolio of pharmaceutical products.